Acuta Capital Partners’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,000
Closed -$108K 48
2022
Q3
$108K Buy
+5,000
New +$108K 0.05% 41